Moreover, our results suggest that the preferential engraftment of MSCs to metastatic regions is promoted by elevated expression of EGF, CXCL9, CCL25, and MMP‐9 by HCC cells both in vitro and in vivo. The gene discussed is EGF; the disease is hepatocellular carcinoma.